Patents Assigned to Neuronetics, Inc.
-
Patent number: 8657731Abstract: The inventive technique includes a system, method and device for treating a patient. The device includes a magnetic device having a core created by a binder process having a relatively low temperature. The device further includes a conductor in electrical communication with the core.Type: GrantFiled: June 5, 2009Date of Patent: February 25, 2014Assignee: Neuronetics, Inc.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron
-
Publication number: 20140012064Abstract: The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location. The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerves and muscle. Also, the second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes. The invention further may include locating a conductor on a treatment area and/or a transcutaneous stimulation device relative to the first location. In addition, the method may further include adjusting how much the transcutaneous stimulation is reduced at the first location.Type: ApplicationFiled: July 10, 2013Publication date: January 9, 2014Applicant: Neuronetics, Inc.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron
-
Patent number: 8517908Abstract: The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location. The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerves and muscle. Also, the second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes. The invention further may include locating a conductor on a treatment area and/or a transcutaneous stimulation device relative to the first location. In addition, the method may further include adjusting how much the transcutaneous stimulation is reduced at the first location.Type: GrantFiled: January 12, 2012Date of Patent: August 27, 2013Assignee: Neuronetics, Inc.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron
-
Patent number: 8506468Abstract: A ferrofluid chamber has a housing that is adapted to be coupled to a component that generates a magnetic field of sufficient strength to stimulate anatomical tissue. In addition, a ferrofluid is disposed within the housing for cooling the component.Type: GrantFiled: May 27, 2008Date of Patent: August 13, 2013Assignee: Neuronetics, Inc.Inventors: Kenneth Ghiron, Mark Edward Riehl
-
Patent number: 8246529Abstract: The inventive technique include a system, method and device for treating a patient. The inventive system includes a magnetic field generating device created using a powdered ferromagnetic. The system further includes a circuit in electrical communication with the magnetic core, and a power source in electrical communication with the circuit. The ferromagnetic powder core may be manufactured by at least one of the following: machining, pressing, molding, gluing, and extruding. Also, the ferromagnetic powder core may have a distributed gap structure, where the gap structure operates to focus the magnetic field between pole faces of the magnetic device.Type: GrantFiled: September 29, 2010Date of Patent: August 21, 2012Assignee: Neuronetics, Inc.Inventors: Mark Edward Riehl, Kenneth Ghiron, Leo P. Carbonneau, Gerard E. Bachand
-
Publication number: 20120209054Abstract: The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location. The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerves and muscle. Also, the second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes. The invention further may include locating a conductor on a treatment area and/or a transcutaneous stimulation device relative to the first location. In addition, the method may further include adjusting how much the transcutaneous stimulation is reduced at the first location.Type: ApplicationFiled: January 12, 2012Publication date: August 16, 2012Applicant: NEURONETICS, INC.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron
-
Publication number: 20120203054Abstract: A proximity sensor for a transcranial magnetic stimulation (TMS) system detects the proximity of a TMS coil assembly to a position at which the coil is to receive pulses during TMS treatment and provides feedback to the operator so that the operator may adjust the TMS coil assembly to maintain optimal positioning during treatment. A flexible substrate containing a sensor or sensor array is disposed between the TMS coil assembly and the position such that the coupling of the TMS coil assembly to the position may be detected by the sensor(s). Sensor outputs are processed by signal processing circuitry to provide an indication of whether the TMS coil assembly is properly disposed with respect to the position during TMS treatment. A display provides an indication of how to adjust the TMS coil assembly to improve the positioning of the TMS coil assembly.Type: ApplicationFiled: April 18, 2012Publication date: August 9, 2012Applicant: NEURONETICS, INC.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron, Stanford W. Miller
-
Patent number: 8177702Abstract: A proximity sensor for a transcranial magnetic stimulation (TMS) system detects the proximity of a TMS coil assembly to a position at which the coil is to receive pulses during TMS treatment and provides feedback to the operator so that the operator may adjust the TMS coil assembly as necessary to maintain optimal positioning during treatment. A flexible substrate containing a sensor or sensor array is disposed between the TMS coil assembly and the position such that the coupling of the TMS coil assembly to the position may be detected by the sensor(s). Sensor outputs are processed by signal processing circuitry to provide an indication of whether the TMS coil assembly is properly disposed with respect to the position during TMS treatment. A display may be used to provide an indication of how to adjust the TMS coil assembly to improve the positioning of the TMS coil assembly.Type: GrantFiled: April 15, 2004Date of Patent: May 15, 2012Assignee: Neuronetics, Inc.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron, Stanford W. Miller
-
Patent number: 8128549Abstract: The inventive technique includes methods, devices and computer-readable media for monitoring a magnetic device. One such device includes a magnetic core for generating a magnetic field, a power supply and a capacitor bank that is charged by the power supply and is for pulsing the magnetic core. The device also includes a processor that measures a charging response of the capacitor bank during charging and determines whether the measured charging response is within a predetermined tolerance of a predetermined charging response.Type: GrantFiled: February 20, 2007Date of Patent: March 6, 2012Assignee: Neuronetics, Inc.Inventors: Anthony Testani, Mark Edward Riehl, Frank C. Klingshirn
-
Patent number: 8118722Abstract: The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location. The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerves and muscle. Also, the second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes. The invention further may include locating a conductor on a treatment area and/or a transcutaneous stimulation device relative to the first location. In addition, the method may further include adjusting how much the transcutaneous stimulation is reduced at the first location.Type: GrantFiled: October 25, 2005Date of Patent: February 21, 2012Assignee: Neuronetics, Inc.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron
-
Patent number: 8088058Abstract: Just one embodiment of the invention includes a device, method and system for positioning a treatment instrument with respect to a patient. The novel device includes a holder for securing the treatment instrument (e.g., a magnetic stimulation device used for transcutaneous magnetic stimulation treatment of depression). The holder allows the treatment instrument to move about the patient. The device also includes a first arm that is coupled to the holder, and a vertical support that is coupled to the first arm. The first arm is substantially transverse to the vertical support, and may rotates about the vertical support in a horizontal axis. Such rotation, as well as movement and rotation of other components with respect to each other may be facilitated by a ball bearing construction.Type: GrantFiled: January 20, 2005Date of Patent: January 3, 2012Assignee: Neuronetics, Inc.Inventors: Vincent A. Juliana, Mark Edward Riehl, Ravi Pillutla
-
Patent number: 7963903Abstract: The inventive technique include a system, method and device for treating a patient. The inventive system includes a magnetic core having a highly saturable magnetic material and a conductor wound around at least a portion of the magnetic core. The magnetic core has a first section with a first end and a second end, a second section with a first end and a second end. The first end of the second section is connected at an angle to the first end of the first section. The magnetic core also has a third section with a first end and a second end. The first end of the third section is connected at an angle to the second end of the second section.Type: GrantFiled: August 26, 2005Date of Patent: June 21, 2011Assignee: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Mark Edward Riehl
-
Publication number: 20110015464Abstract: The inventive technique include a system, method and device for treating a patient. The inventive system includes a magnetic field generating device created using a powdered ferromagnetic. The system further includes a circuit in electrical communication with the magnetic core, and a power source in electrical communication with the circuit. The ferromagnetic powder core may be manufactured by at least one of the following: machining, pressing, molding, gluing, and extruding. Also, the ferromagnetic powder core may have a distributed gap structure, where the gap structure operates to focus the magnetic field between pole faces of the magnetic device.Type: ApplicationFiled: September 29, 2010Publication date: January 20, 2011Applicant: NEURONETICS, INC.Inventors: Mark Edward Riehl, Kenneth Ghiron, Leo P. Carbonneau, Gerard E. Bachand
-
Patent number: 7824324Abstract: The inventive technique include a system, method and device for treating a patient. The inventive system includes a magnetic field generating device created using a powdered ferromagnetic. The system further includes a circuit in electrical communication with the magnetic core, and a power source in electrical communication with the circuit. The ferromagnetic powder core may be manufactured by at least one of the following: machining, pressing, molding, gluing, and extruding. Also, the ferromagnetic powder core may have a distributed gap structure, where the gap structure operates to focus the magnetic field between pole faces of the magnetic device.Type: GrantFiled: July 27, 2005Date of Patent: November 2, 2010Assignee: Neuronetics, Inc.Inventors: Mark Edward Riehl, Kenneth P. Ghiron, Leo P. Carbonneau, Gerard E. Bachand
-
Patent number: 7651459Abstract: A device provides simple positioning of the patient's head and simple positioning of the TMS coil relative to a coordinate system of the patient's head once the head is positioned. The TMS coil is fixed at a treatment position in the coordinate system of the patient's head and the position in the coordinate system is recorded for use in subsequent clinical sessions. A positioner assembly supports the weight of the TMS coil and allows the operator to freely move the TMS coil to search for the patient's motor threshold position (MTP) and/or the treatment position (TXP). If the TXP is in registration with the MTP, once the MTP is determined, the positioner assembly requires only a single adjustment of the magnet position to locate the TXP where the coil is locked in place for the duration of the TMS therapy.Type: GrantFiled: January 6, 2004Date of Patent: January 26, 2010Assignee: Neuronetics, Inc.Inventors: Allan Cameron, John A. MacNeill, Gregg Flender, Mark Edward Riehl
-
Patent number: 7614996Abstract: The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location. The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerves and muscle. Also, the second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes. The invention further may include locating a conductor on a treatment area and/or a transcutaneous stimulation device relative to the first location. In addition, the method may further include adjusting how much the transcutaneous stimulation is reduced at the first location.Type: GrantFiled: December 5, 2003Date of Patent: November 10, 2009Assignee: Neuronetics, Inc.Inventors: Mark Edward Riehl, Stanford W. Miller
-
Patent number: 7601115Abstract: The invention provides a method for treating a patient for mental illnesses, such as depression, by applying a magnetic field to the patient, producing a seizure in the patient as a function of a strength of the magnetic field, and preventing further stimulation from the magnetic field when the seizure is in progress. Such Magnetic Seizure Therapy (MST) does not include many of the known side effects of electroconvulsive therapy (ECT).Type: GrantFiled: May 24, 2004Date of Patent: October 13, 2009Assignee: Neuronetics, Inc.Inventor: Mark Edward Riehl
-
Publication number: 20090247808Abstract: The inventive technique includes a system, method and device for treating a patient. The device includes a magnetic device having a core created by a binder process having a relatively low temperature. The device further includes a conductor in electrical communication with the core.Type: ApplicationFiled: June 5, 2009Publication date: October 1, 2009Applicant: Neuronetics, Inc.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron
-
Publication number: 20090240096Abstract: The inventive technique includes a system, method and device for treating a patient. The device includes a magnetic device having a core created by a binder process having a relatively low temperature. The device further includes a conductor in electrical communication with the core.Type: ApplicationFiled: June 5, 2009Publication date: September 24, 2009Applicant: NEURONETICS, INC.Inventors: Mark Edward Riehl, Kenneth Marc Ghiron
-
Publication number: 20090227830Abstract: A method and device provide simple positioning of a TMS coil relative to a coordinate system of the patient's head while allowing flexible positioning of the patient's head. The system includes a mobile console on a wheeled base that integrates various subsystems and supports a mast that, in turn, supports a coil gantry that supports a TMS coil assembly. The coil gantry includes a balance arm with a counterbalance and a halo assembly that connects to the coil. The coil gantry supports the weight of the coil and allows free movement of the coil in all dimensions for easy placement on the patient's head. A head support and coil alignment unit includes several parts that are designed to provide maximum patient comfort and reliable coil position measurement of the patient's motor threshold (MT) location and TMS treatment location. The head support and coil alignment unit aligns the patient's head and holds the head in place relative to the coil during TMS treatment.Type: ApplicationFiled: March 10, 2008Publication date: September 10, 2009Applicant: NEURONETICS, INC.Inventors: Ravi Pillutla, Vincent A. Juliana, Mark E. Riehl